nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ORM1—Quinidine—malaria	0.0826	0.135	CbGbCtD
Tacrolimus—CYP3A5—Artemether—malaria	0.0524	0.086	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Quinine—malaria	0.0424	0.0695	CbGbCtD
Tacrolimus—CYP3A7—Quinine—malaria	0.0424	0.0695	CbGbCtD
Tacrolimus—CYP3A4—Clindamycin—malaria	0.0419	0.0687	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Quinidine—malaria	0.0372	0.0611	CbGbCtD
Tacrolimus—CYP3A7—Quinidine—malaria	0.0372	0.0611	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Dapsone—malaria	0.0321	0.0527	CbGbCtD
Tacrolimus—CYP3A7—Dapsone—malaria	0.0321	0.0527	CbGbCtD
Tacrolimus—CYP3A5—Quinine—malaria	0.0318	0.0521	CbGbCtD
Tacrolimus—CYP3A5—Dapsone—malaria	0.0241	0.0395	CbGbCtD
Tacrolimus—CYP3A4—Sulfadiazine—malaria	0.024	0.0395	CbGbCtD
Tacrolimus—ABCB1—Quinine—malaria	0.0207	0.0339	CbGbCtD
Tacrolimus—CYP3A4—Artemether—malaria	0.0204	0.0335	CbGbCtD
Tacrolimus—CYP3A4—Proguanil—malaria	0.0192	0.0315	CbGbCtD
Tacrolimus—CYP3A4—Doxycycline—malaria	0.0182	0.0299	CbGbCtD
Tacrolimus—ABCB1—Quinidine—malaria	0.0182	0.0298	CbGbCtD
Tacrolimus—CYP3A4—Quinine—malaria	0.0124	0.0203	CbGbCtD
Tacrolimus—CYP3A4—Quinidine—malaria	0.0109	0.0179	CbGbCtD
Tacrolimus—CYP3A4—Dapsone—malaria	0.00939	0.0154	CbGbCtD
Tacrolimus—ORM1—saliva—malaria	0.00615	0.0713	CbGeAlD
Tacrolimus—PPP3CA—blood plasma—malaria	0.00514	0.0597	CbGeAlD
Tacrolimus—ABCA5—saliva-secreting gland—malaria	0.00441	0.0512	CbGeAlD
Tacrolimus—MTOR—blood plasma—malaria	0.0038	0.0441	CbGeAlD
Tacrolimus—FKBP1A—blood plasma—malaria	0.00342	0.0397	CbGeAlD
Tacrolimus—PPP3CA—saliva-secreting gland—malaria	0.00298	0.0346	CbGeAlD
Tacrolimus—PPP3CA—hematopoietic system—malaria	0.00284	0.033	CbGeAlD
Tacrolimus—ABCA5—blood—malaria	0.00279	0.0324	CbGeAlD
Tacrolimus—ABCA5—bone marrow—malaria	0.0027	0.0313	CbGeAlD
Tacrolimus—PPP3CA—kidney—malaria	0.00233	0.0271	CbGeAlD
Tacrolimus—ABCA5—liver—malaria	0.00218	0.0253	CbGeAlD
Tacrolimus—MTOR—hematopoietic system—malaria	0.0021	0.0244	CbGeAlD
Tacrolimus—PPP3CA—digestive system—malaria	0.00198	0.023	CbGeAlD
Tacrolimus—FKBP1A—hematopoietic system—malaria	0.00189	0.0219	CbGeAlD
Tacrolimus—PPP3CA—blood—malaria	0.00188	0.0219	CbGeAlD
Tacrolimus—PPP3CA—bone marrow—malaria	0.00182	0.0212	CbGeAlD
Tacrolimus—ABCA5—brain—malaria	0.00173	0.0201	CbGeAlD
Tacrolimus—MTOR—kidney—malaria	0.00172	0.02	CbGeAlD
Tacrolimus—FKBP1A—kidney—malaria	0.00155	0.018	CbGeAlD
Tacrolimus—CYP3A5—blood plasma—malaria	0.00149	0.0173	CbGeAlD
Tacrolimus—ORM1—hematopoietic system—malaria	0.00148	0.0172	CbGeAlD
Tacrolimus—PPP3CA—liver—malaria	0.00147	0.0171	CbGeAlD
Tacrolimus—MTOR—digestive system—malaria	0.00146	0.017	CbGeAlD
Tacrolimus—MTOR—blood—malaria	0.00139	0.0162	CbGeAlD
Tacrolimus—MTOR—bone marrow—malaria	0.00135	0.0156	CbGeAlD
Tacrolimus—FKBP1A—digestive system—malaria	0.00131	0.0153	CbGeAlD
Tacrolimus—FKBP1A—blood—malaria	0.00125	0.0145	CbGeAlD
Tacrolimus—FKBP1A—bone marrow—malaria	0.00121	0.0141	CbGeAlD
Tacrolimus—CYP3A7—liver—malaria	0.00121	0.0141	CbGeAlD
Tacrolimus—PPP3CA—brain—malaria	0.00117	0.0136	CbGeAlD
Tacrolimus—CYP3A4—blood plasma—malaria	0.00112	0.013	CbGeAlD
Tacrolimus—MTOR—liver—malaria	0.00109	0.0126	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—liver—malaria	0.00103	0.012	CbGeAlD
Tacrolimus—ORM1—blood—malaria	0.00098	0.0114	CbGeAlD
Tacrolimus—FKBP1A—liver—malaria	0.000979	0.0114	CbGeAlD
Tacrolimus—ORM1—bone marrow—malaria	0.000948	0.011	CbGeAlD
Tacrolimus—MTOR—brain—malaria	0.000864	0.01	CbGeAlD
Tacrolimus—CYP3A5—hematopoietic system—malaria	0.000823	0.00955	CbGeAlD
Tacrolimus—ABCB1—blood plasma—malaria	0.00079	0.00917	CbGeAlD
Tacrolimus—FKBP1A—brain—malaria	0.000777	0.00902	CbGeAlD
Tacrolimus—ORM1—liver—malaria	0.000766	0.0089	CbGeAlD
Tacrolimus—CYP3A5—kidney—malaria	0.000674	0.00783	CbGeAlD
Tacrolimus—ALB—liver—malaria	0.000672	0.0078	CbGeAlD
Tacrolimus—CYP3A4—hematopoietic system—malaria	0.000617	0.00717	CbGeAlD
Tacrolimus—CYP3A5—digestive system—malaria	0.000572	0.00664	CbGeAlD
Tacrolimus—CYP3A5—blood—malaria	0.000545	0.00633	CbGeAlD
Tacrolimus—ALB—brain—malaria	0.000533	0.00619	CbGeAlD
Tacrolimus—CYP3A4—kidney—malaria	0.000506	0.00587	CbGeAlD
Tacrolimus—ABCB1—hematopoietic system—malaria	0.000437	0.00507	CbGeAlD
Tacrolimus—CYP3A4—digestive system—malaria	0.000429	0.00498	CbGeAlD
Tacrolimus—CYP3A5—liver—malaria	0.000426	0.00495	CbGeAlD
Tacrolimus—CYP3A4—blood—malaria	0.000409	0.00475	CbGeAlD
Tacrolimus—ABCB1—kidney—malaria	0.000358	0.00416	CbGeAlD
Tacrolimus—CYP3A4—liver—malaria	0.00032	0.00371	CbGeAlD
Tacrolimus—ABCB1—digestive system—malaria	0.000304	0.00353	CbGeAlD
Tacrolimus—ABCB1—blood—malaria	0.00029	0.00336	CbGeAlD
Tacrolimus—ABCB1—bone marrow—malaria	0.00028	0.00325	CbGeAlD
Tacrolimus—ABCB1—liver—malaria	0.000226	0.00263	CbGeAlD
Tacrolimus—PPP3CA—Signaling by GPCR—ACKR1—malaria	0.000183	0.0036	CbGpPWpGaD
Tacrolimus—ABCB1—brain—malaria	0.00018	0.00209	CbGeAlD
Tacrolimus—MTOR—IL12-mediated signaling events—IFNG—malaria	0.000179	0.00352	CbGpPWpGaD
Tacrolimus—MTOR—IL12-mediated signaling events—CD4—malaria	0.000173	0.0034	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TIRAP—malaria	0.00017	0.00335	CbGpPWpGaD
Tacrolimus—CYP3A7—Biological oxidations—HPGDS—malaria	0.000167	0.0033	CbGpPWpGaD
Tacrolimus—Eye disorder—Quinidine barbiturate—malaria	0.000166	0.000655	CcSEcCtD
Tacrolimus—Tinnitus—Quinidine barbiturate—malaria	0.000166	0.000653	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Sulfadiazine—malaria	0.000165	0.000652	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL1B—malaria	0.000165	0.00325	CbGpPWpGaD
Tacrolimus—Flushing—Quinidine barbiturate—malaria	0.000165	0.00065	CcSEcCtD
Tacrolimus—Cardiac disorder—Quinidine barbiturate—malaria	0.000165	0.00065	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL2—malaria	0.000165	0.00324	CbGpPWpGaD
Tacrolimus—Flushing—Pentoxifylline—malaria	0.000164	0.000649	CcSEcCtD
Tacrolimus—ALB—Selenium Micronutrient Network—SCARB1—malaria	0.000163	0.00322	CbGpPWpGaD
Tacrolimus—Vertigo—Dapsone—malaria	0.000162	0.00064	CcSEcCtD
Tacrolimus—MTOR—Regulation of Telomerase—IFNG—malaria	0.000162	0.00319	CbGpPWpGaD
Tacrolimus—Vision blurred—Quinidine—malaria	0.000161	0.000637	CcSEcCtD
Tacrolimus—Vision blurred—Quinine—malaria	0.000161	0.000637	CcSEcCtD
Tacrolimus—Anaemia—Clindamycin—malaria	0.000161	0.000637	CcSEcCtD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—IL1B—malaria	0.000161	0.00316	CbGpPWpGaD
Tacrolimus—Tremor—Quinine—malaria	0.00016	0.000633	CcSEcCtD
Tacrolimus—Tremor—Quinidine—malaria	0.00016	0.000633	CcSEcCtD
Tacrolimus—Immune system disorder—Quinidine barbiturate—malaria	0.00016	0.000633	CcSEcCtD
Tacrolimus—Immune system disorder—Pentoxifylline—malaria	0.00016	0.000631	CcSEcCtD
Tacrolimus—Mediastinal disorder—Quinidine barbiturate—malaria	0.00016	0.000631	CcSEcCtD
Tacrolimus—MTOR—IL12-mediated signaling events—IL1B—malaria	0.00016	0.00314	CbGpPWpGaD
Tacrolimus—Chills—Quinidine barbiturate—malaria	0.000159	0.000628	CcSEcCtD
Tacrolimus—MTOR—IL12-mediated signaling events—IL2—malaria	0.000159	0.00313	CbGpPWpGaD
Tacrolimus—Arrhythmia—Pentoxifylline—malaria	0.000158	0.000625	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—CR1—malaria	0.000158	0.00312	CbGpPWpGaD
Tacrolimus—Cough—Dapsone—malaria	0.000158	0.000621	CcSEcCtD
Tacrolimus—Agitation—Quinine—malaria	0.000157	0.000621	CcSEcCtD
Tacrolimus—Agitation—Quinidine—malaria	0.000157	0.000621	CcSEcCtD
Tacrolimus—Vertigo—Clindamycin—malaria	0.000157	0.000619	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Sulfadiazine—malaria	0.000156	0.000617	CcSEcCtD
Tacrolimus—MTOR—Costimulation by the CD28 family—CD4—malaria	0.000156	0.00308	CbGpPWpGaD
Tacrolimus—Leukopenia—Clindamycin—malaria	0.000156	0.000616	CcSEcCtD
Tacrolimus—Mental disorder—Quinidine barbiturate—malaria	0.000156	0.000614	CcSEcCtD
Tacrolimus—Malnutrition—Quinidine barbiturate—malaria	0.000155	0.00061	CcSEcCtD
Tacrolimus—Erythema—Quinidine barbiturate—malaria	0.000155	0.00061	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—TNF—malaria	0.000155	0.00305	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—KDR—malaria	0.000154	0.00304	CbGpPWpGaD
Tacrolimus—Erythema—Pentoxifylline—malaria	0.000154	0.000609	CcSEcCtD
Tacrolimus—Vertigo—Quinidine—malaria	0.000154	0.000607	CcSEcCtD
Tacrolimus—Vertigo—Quinine—malaria	0.000154	0.000607	CcSEcCtD
Tacrolimus—Syncope—Quinidine—malaria	0.000154	0.000606	CcSEcCtD
Tacrolimus—Syncope—Quinine—malaria	0.000154	0.000606	CcSEcCtD
Tacrolimus—Leukopenia—Quinine—malaria	0.000153	0.000605	CcSEcCtD
Tacrolimus—Leukopenia—Quinidine—malaria	0.000153	0.000605	CcSEcCtD
Tacrolimus—Flatulence—Pentoxifylline—malaria	0.000152	0.0006	CcSEcCtD
Tacrolimus—Urticaria—Sulfadiazine—malaria	0.000152	0.0006	CcSEcCtD
Tacrolimus—Tension—Quinidine barbiturate—malaria	0.000152	0.000598	CcSEcCtD
Tacrolimus—Tension—Pentoxifylline—malaria	0.000151	0.000597	CcSEcCtD
Tacrolimus—Palpitations—Quinidine—malaria	0.000151	0.000597	CcSEcCtD
Tacrolimus—Palpitations—Quinine—malaria	0.000151	0.000597	CcSEcCtD
Tacrolimus—Body temperature increased—Sulfadiazine—malaria	0.000151	0.000597	CcSEcCtD
Tacrolimus—Abdominal pain—Sulfadiazine—malaria	0.000151	0.000597	CcSEcCtD
Tacrolimus—Dysgeusia—Pentoxifylline—malaria	0.000151	0.000596	CcSEcCtD
Tacrolimus—Hypertension—Clindamycin—malaria	0.000151	0.000595	CcSEcCtD
Tacrolimus—Loss of consciousness—Quinidine—malaria	0.000151	0.000594	CcSEcCtD
Tacrolimus—Loss of consciousness—Quinine—malaria	0.000151	0.000594	CcSEcCtD
Tacrolimus—Nervousness—Quinidine barbiturate—malaria	0.00015	0.000592	CcSEcCtD
Tacrolimus—Nervousness—Pentoxifylline—malaria	0.00015	0.000591	CcSEcCtD
Tacrolimus—Back pain—Pentoxifylline—malaria	0.000149	0.000589	CcSEcCtD
Tacrolimus—Convulsion—Quinine—malaria	0.000148	0.000585	CcSEcCtD
Tacrolimus—Convulsion—Quinidine—malaria	0.000148	0.000585	CcSEcCtD
Tacrolimus—Muscle spasms—Pentoxifylline—malaria	0.000148	0.000585	CcSEcCtD
Tacrolimus—Discomfort—Clindamycin—malaria	0.000147	0.000579	CcSEcCtD
Tacrolimus—PPP3CA—Disease—PKLR—malaria	0.000146	0.00288	CbGpPWpGaD
Tacrolimus—Myalgia—Quinidine—malaria	0.000146	0.000575	CcSEcCtD
Tacrolimus—Chest pain—Quinidine—malaria	0.000146	0.000575	CcSEcCtD
Tacrolimus—Chest pain—Quinine—malaria	0.000146	0.000575	CcSEcCtD
Tacrolimus—Myalgia—Quinine—malaria	0.000146	0.000575	CcSEcCtD
Tacrolimus—MTOR—Signaling by VEGF—KDR—malaria	0.000146	0.00287	CbGpPWpGaD
Tacrolimus—Vision blurred—Quinidine barbiturate—malaria	0.000146	0.000575	CcSEcCtD
Tacrolimus—Vision blurred—Pentoxifylline—malaria	0.000145	0.000574	CcSEcCtD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000145	0.00286	CbGpPWpGaD
Tacrolimus—Tremor—Quinidine barbiturate—malaria	0.000145	0.000571	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000145	0.000571	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000145	0.000571	CcSEcCtD
Tacrolimus—Tremor—Pentoxifylline—malaria	0.000145	0.00057	CcSEcCtD
Tacrolimus—MTOR—Regulation of Telomerase—IL2—malaria	0.000144	0.00283	CbGpPWpGaD
Tacrolimus—Tachycardia—Dapsone—malaria	0.000144	0.000567	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—IL12B—malaria	0.000144	0.00283	CbGpPWpGaD
Tacrolimus—Ill-defined disorder—Pentoxifylline—malaria	0.000143	0.000565	CcSEcCtD
Tacrolimus—ALB—Vitamin B12 Metabolism—CRP—malaria	0.000143	0.00282	CbGpPWpGaD
Tacrolimus—Anaemia—Pentoxifylline—malaria	0.000143	0.000563	CcSEcCtD
Tacrolimus—Anaphylactic shock—Clindamycin—malaria	0.000142	0.000562	CcSEcCtD
Tacrolimus—Agitation—Quinidine barbiturate—malaria	0.000142	0.00056	CcSEcCtD
Tacrolimus—Agitation—Pentoxifylline—malaria	0.000142	0.000559	CcSEcCtD
Tacrolimus—Hypersensitivity—Sulfadiazine—malaria	0.000141	0.000556	CcSEcCtD
Tacrolimus—Confusional state—Quinidine—malaria	0.000141	0.000556	CcSEcCtD
Tacrolimus—Confusional state—Quinine—malaria	0.000141	0.000556	CcSEcCtD
Tacrolimus—Oedema—Quinidine—malaria	0.00014	0.000551	CcSEcCtD
Tacrolimus—Oedema—Quinine—malaria	0.00014	0.000551	CcSEcCtD
Tacrolimus—Thrombocytopenia—Clindamycin—malaria	0.00014	0.00055	CcSEcCtD
Tacrolimus—Malaise—Pentoxifylline—malaria	0.000139	0.000549	CcSEcCtD
Tacrolimus—Vertigo—Quinidine barbiturate—malaria	0.000139	0.000548	CcSEcCtD
Tacrolimus—Syncope—Quinidine barbiturate—malaria	0.000139	0.000547	CcSEcCtD
Tacrolimus—Leukopenia—Quinidine barbiturate—malaria	0.000138	0.000546	CcSEcCtD
Tacrolimus—Leukopenia—Pentoxifylline—malaria	0.000138	0.000545	CcSEcCtD
Tacrolimus—Shock—Quinidine—malaria	0.000138	0.000542	CcSEcCtD
Tacrolimus—Shock—Quinine—malaria	0.000138	0.000542	CcSEcCtD
Tacrolimus—MTOR—Adaptive Immune System—FCGR2B—malaria	0.000137	0.0027	CbGpPWpGaD
Tacrolimus—Nervous system disorder—Quinine—malaria	0.000137	0.000541	CcSEcCtD
Tacrolimus—Nervous system disorder—Quinidine—malaria	0.000137	0.000541	CcSEcCtD
Tacrolimus—Thrombocytopenia—Quinine—malaria	0.000137	0.00054	CcSEcCtD
Tacrolimus—Thrombocytopenia—Quinidine—malaria	0.000137	0.00054	CcSEcCtD
Tacrolimus—Palpitations—Quinidine barbiturate—malaria	0.000137	0.000539	CcSEcCtD
Tacrolimus—Tachycardia—Quinidine—malaria	0.000136	0.000538	CcSEcCtD
Tacrolimus—Tachycardia—Quinine—malaria	0.000136	0.000538	CcSEcCtD
Tacrolimus—Palpitations—Pentoxifylline—malaria	0.000136	0.000538	CcSEcCtD
Tacrolimus—Loss of consciousness—Quinidine barbiturate—malaria	0.000136	0.000536	CcSEcCtD
Tacrolimus—Skin disorder—Quinine—malaria	0.000136	0.000536	CcSEcCtD
Tacrolimus—Skin disorder—Quinidine—malaria	0.000136	0.000536	CcSEcCtD
Tacrolimus—Pruritus—Sulfadiazine—malaria	0.000135	0.000534	CcSEcCtD
Tacrolimus—Hyperhidrosis—Quinine—malaria	0.000135	0.000533	CcSEcCtD
Tacrolimus—Hyperhidrosis—Quinidine—malaria	0.000135	0.000533	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—IL4—malaria	0.000135	0.00265	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TLR9—malaria	0.000135	0.00265	CbGpPWpGaD
Tacrolimus—Convulsion—Quinidine barbiturate—malaria	0.000134	0.000528	CcSEcCtD
Tacrolimus—Convulsion—Pentoxifylline—malaria	0.000134	0.000527	CcSEcCtD
Tacrolimus—MTOR—Leptin signaling pathway—IL1B—malaria	0.000133	0.00263	CbGpPWpGaD
Tacrolimus—Anorexia—Quinine—malaria	0.000133	0.000526	CcSEcCtD
Tacrolimus—Anorexia—Quinidine—malaria	0.000133	0.000526	CcSEcCtD
Tacrolimus—Insomnia—Dapsone—malaria	0.000133	0.000526	CcSEcCtD
Tacrolimus—Hypertension—Pentoxifylline—malaria	0.000133	0.000525	CcSEcCtD
Tacrolimus—Hypotension—Clindamycin—malaria	0.000133	0.000525	CcSEcCtD
Tacrolimus—MTOR—CXCR4-mediated signaling events—CD4—malaria	0.000132	0.0026	CbGpPWpGaD
Tacrolimus—Chest pain—Quinidine barbiturate—malaria	0.000132	0.000519	CcSEcCtD
Tacrolimus—Myalgia—Quinidine barbiturate—malaria	0.000132	0.000519	CcSEcCtD
Tacrolimus—Arthralgia—Quinidine barbiturate—malaria	0.000132	0.000519	CcSEcCtD
Tacrolimus—ALB—Vitamin B12 Metabolism—ICAM1—malaria	0.000132	0.00259	CbGpPWpGaD
Tacrolimus—Chest pain—Pentoxifylline—malaria	0.000131	0.000518	CcSEcCtD
Tacrolimus—Myalgia—Pentoxifylline—malaria	0.000131	0.000518	CcSEcCtD
Tacrolimus—Anxiety—Quinidine barbiturate—malaria	0.000131	0.000517	CcSEcCtD
Tacrolimus—Diarrhoea—Sulfadiazine—malaria	0.000131	0.000516	CcSEcCtD
Tacrolimus—Anxiety—Pentoxifylline—malaria	0.000131	0.000516	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000131	0.000516	CcSEcCtD
Tacrolimus—Hypotension—Quinidine—malaria	0.000131	0.000515	CcSEcCtD
Tacrolimus—Hypotension—Quinine—malaria	0.000131	0.000515	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00013	0.000515	CcSEcCtD
Tacrolimus—PPP3CA—Disease—G6PD—malaria	0.00013	0.00257	CbGpPWpGaD
Tacrolimus—Discomfort—Pentoxifylline—malaria	0.00013	0.000512	CcSEcCtD
Tacrolimus—Dry mouth—Pentoxifylline—malaria	0.000128	0.000507	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—TIRAP—malaria	0.000127	0.00251	CbGpPWpGaD
Tacrolimus—Musculoskeletal discomfort—Quinidine—malaria	0.000127	0.000502	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Quinine—malaria	0.000127	0.000502	CcSEcCtD
Tacrolimus—Confusional state—Quinidine barbiturate—malaria	0.000127	0.000502	CcSEcCtD
Tacrolimus—Dyspnoea—Clindamycin—malaria	0.000127	0.000501	CcSEcCtD
Tacrolimus—Confusional state—Pentoxifylline—malaria	0.000127	0.000501	CcSEcCtD
Tacrolimus—Oedema—Quinidine barbiturate—malaria	0.000126	0.000498	CcSEcCtD
Tacrolimus—Anaphylactic shock—Pentoxifylline—malaria	0.000126	0.000497	CcSEcCtD
Tacrolimus—Oedema—Pentoxifylline—malaria	0.000126	0.000497	CcSEcCtD
Tacrolimus—Dyspepsia—Clindamycin—malaria	0.000125	0.000495	CcSEcCtD
Tacrolimus—Infection—Pentoxifylline—malaria	0.000125	0.000493	CcSEcCtD
Tacrolimus—PPP3CA—Spinal Cord Injury—IL6—malaria	0.000125	0.00246	CbGpPWpGaD
Tacrolimus—Dyspnoea—Quinidine—malaria	0.000125	0.000492	CcSEcCtD
Tacrolimus—Dyspnoea—Quinine—malaria	0.000125	0.000492	CcSEcCtD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—TNF—malaria	0.000124	0.00245	CbGpPWpGaD
Tacrolimus—Shock—Quinidine barbiturate—malaria	0.000124	0.00049	CcSEcCtD
Tacrolimus—Shock—Pentoxifylline—malaria	0.000124	0.000489	CcSEcCtD
Tacrolimus—Nervous system disorder—Quinidine barbiturate—malaria	0.000124	0.000488	CcSEcCtD
Tacrolimus—Thrombocytopenia—Quinidine barbiturate—malaria	0.000124	0.000487	CcSEcCtD
Tacrolimus—Thrombocytopenia—Pentoxifylline—malaria	0.000123	0.000486	CcSEcCtD
Tacrolimus—Tachycardia—Quinidine barbiturate—malaria	0.000123	0.000486	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Clindamycin—malaria	0.000123	0.000485	CcSEcCtD
Tacrolimus—Tachycardia—Pentoxifylline—malaria	0.000123	0.000485	CcSEcCtD
Tacrolimus—Fatigue—Clindamycin—malaria	0.000123	0.000485	CcSEcCtD
Tacrolimus—Skin disorder—Quinidine barbiturate—malaria	0.000123	0.000483	CcSEcCtD
Tacrolimus—Skin disorder—Pentoxifylline—malaria	0.000122	0.000482	CcSEcCtD
Tacrolimus—Hyperhidrosis—Quinidine barbiturate—malaria	0.000122	0.000481	CcSEcCtD
Tacrolimus—Pain—Clindamycin—malaria	0.000122	0.000481	CcSEcCtD
Tacrolimus—Constipation—Clindamycin—malaria	0.000122	0.000481	CcSEcCtD
Tacrolimus—MTOR—DAP12 interactions—HLA-B—malaria	0.000122	0.0024	CbGpPWpGaD
Tacrolimus—Hyperhidrosis—Pentoxifylline—malaria	0.000122	0.00048	CcSEcCtD
Tacrolimus—Vomiting—Sulfadiazine—malaria	0.000122	0.00048	CcSEcCtD
Tacrolimus—Decreased appetite—Quinine—malaria	0.000122	0.000479	CcSEcCtD
Tacrolimus—Decreased appetite—Quinidine—malaria	0.000122	0.000479	CcSEcCtD
Tacrolimus—CYP3A5—Biological oxidations—HPGDS—malaria	0.000121	0.00238	CbGpPWpGaD
Tacrolimus—Gastrointestinal disorder—Quinine—malaria	0.000121	0.000476	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Quinidine—malaria	0.000121	0.000476	CcSEcCtD
Tacrolimus—Rash—Sulfadiazine—malaria	0.000121	0.000476	CcSEcCtD
Tacrolimus—Dermatitis—Sulfadiazine—malaria	0.000121	0.000475	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dapsone—malaria	0.00012	0.000475	CcSEcCtD
Tacrolimus—Anorexia—Quinidine barbiturate—malaria	0.00012	0.000474	CcSEcCtD
Tacrolimus—Anorexia—Pentoxifylline—malaria	0.00012	0.000473	CcSEcCtD
Tacrolimus—Headache—Sulfadiazine—malaria	0.00012	0.000473	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—TNF—malaria	0.00012	0.00236	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CR1—malaria	0.000118	0.00233	CbGpPWpGaD
Tacrolimus—Hypotension—Quinidine barbiturate—malaria	0.000118	0.000465	CcSEcCtD
Tacrolimus—Hypotension—Pentoxifylline—malaria	0.000118	0.000464	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Clindamycin—malaria	0.000117	0.00046	CcSEcCtD
Tacrolimus—PPP3CA—MAPK Signaling Pathway—TNF—malaria	0.000116	0.0023	CbGpPWpGaD
Tacrolimus—Body temperature increased—Dapsone—malaria	0.000116	0.000459	CcSEcCtD
Tacrolimus—Abdominal pain—Dapsone—malaria	0.000116	0.000459	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—CRP—malaria	0.000116	0.00229	CbGpPWpGaD
Tacrolimus—Feeling abnormal—Quinidine—malaria	0.000115	0.000454	CcSEcCtD
Tacrolimus—Feeling abnormal—Quinine—malaria	0.000115	0.000454	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000115	0.000453	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000115	0.000453	CcSEcCtD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IFNG—malaria	0.000114	0.00225	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Quinidine—malaria	0.000114	0.000451	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Quinine—malaria	0.000114	0.000451	CcSEcCtD
Tacrolimus—Insomnia—Pentoxifylline—malaria	0.000114	0.000449	CcSEcCtD
Tacrolimus—Nausea—Sulfadiazine—malaria	0.000114	0.000448	CcSEcCtD
Tacrolimus—MTOR—TSLP Signaling Pathway—IL6—malaria	0.000114	0.00224	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PKLR—malaria	0.000113	0.00223	CbGpPWpGaD
Tacrolimus—Urticaria—Clindamycin—malaria	0.000113	0.000446	CcSEcCtD
Tacrolimus—Abdominal pain—Clindamycin—malaria	0.000113	0.000444	CcSEcCtD
Tacrolimus—Body temperature increased—Clindamycin—malaria	0.000113	0.000444	CcSEcCtD
Tacrolimus—Dyspnoea—Quinidine barbiturate—malaria	0.000112	0.000444	CcSEcCtD
Tacrolimus—Dyspnoea—Pentoxifylline—malaria	0.000112	0.000443	CcSEcCtD
Tacrolimus—Somnolence—Quinidine barbiturate—malaria	0.000112	0.000442	CcSEcCtD
Tacrolimus—Somnolence—Pentoxifylline—malaria	0.000112	0.000442	CcSEcCtD
Tacrolimus—Urticaria—Quinidine—malaria	0.000111	0.000438	CcSEcCtD
Tacrolimus—Urticaria—Quinine—malaria	0.000111	0.000438	CcSEcCtD
Tacrolimus—Dyspepsia—Pentoxifylline—malaria	0.000111	0.000437	CcSEcCtD
Tacrolimus—ALB—Platelet degranulation—CD36—malaria	0.000111	0.00218	CbGpPWpGaD
Tacrolimus—Body temperature increased—Quinine—malaria	0.000111	0.000436	CcSEcCtD
Tacrolimus—Abdominal pain—Quinidine—malaria	0.000111	0.000436	CcSEcCtD
Tacrolimus—Abdominal pain—Quinine—malaria	0.000111	0.000436	CcSEcCtD
Tacrolimus—Body temperature increased—Quinidine—malaria	0.000111	0.000436	CcSEcCtD
Tacrolimus—Decreased appetite—Quinidine barbiturate—malaria	0.00011	0.000433	CcSEcCtD
Tacrolimus—Decreased appetite—Pentoxifylline—malaria	0.000109	0.000432	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000109	0.00043	CcSEcCtD
Tacrolimus—PPP3CA—Innate Immune System—HLA-B—malaria	0.000108	0.00214	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ACKR1—malaria	0.000108	0.00213	CbGpPWpGaD
Tacrolimus—Constipation—Quinidine barbiturate—malaria	0.000108	0.000426	CcSEcCtD
Tacrolimus—Pain—Quinidine barbiturate—malaria	0.000108	0.000426	CcSEcCtD
Tacrolimus—Constipation—Pentoxifylline—malaria	0.000108	0.000425	CcSEcCtD
Tacrolimus—PPP3CA—Immune System—FCGR2A—malaria	0.000108	0.00212	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—ICAM1—malaria	0.000107	0.00211	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CD36—malaria	0.000106	0.0021	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—CD36—malaria	0.000105	0.00208	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—CD40LG—malaria	0.000105	0.00207	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL10—malaria	0.000105	0.00207	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Clindamycin—malaria	0.000105	0.000414	CcSEcCtD
Tacrolimus—Feeling abnormal—Quinidine barbiturate—malaria	0.000104	0.00041	CcSEcCtD
Tacrolimus—Feeling abnormal—Pentoxifylline—malaria	0.000104	0.000409	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000103	0.000407	CcSEcCtD
Tacrolimus—Hypersensitivity—Quinine—malaria	0.000103	0.000406	CcSEcCtD
Tacrolimus—Hypersensitivity—Quinidine—malaria	0.000103	0.000406	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Pentoxifylline—malaria	0.000103	0.000406	CcSEcCtD
Tacrolimus—Asthenia—Clindamycin—malaria	0.000102	0.000403	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—IL4—malaria	0.000102	0.00201	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—malaria	0.000102	0.00201	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—G6PD—malaria	0.000101	0.00199	CbGpPWpGaD
Tacrolimus—Pruritus—Clindamycin—malaria	0.000101	0.000398	CcSEcCtD
Tacrolimus—MTOR—Innate Immune System—TLR9—malaria	0.000101	0.00198	CbGpPWpGaD
Tacrolimus—Asthenia—Quinine—malaria	0.0001	0.000396	CcSEcCtD
Tacrolimus—Asthenia—Quinidine—malaria	0.0001	0.000396	CcSEcCtD
Tacrolimus—Urticaria—Quinidine barbiturate—malaria	0.0001	0.000395	CcSEcCtD
Tacrolimus—ALB—Vitamin B12 Metabolism—IFNG—malaria	0.0001	0.00197	CbGpPWpGaD
Tacrolimus—Urticaria—Pentoxifylline—malaria	0.0001	0.000395	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—HLA-B—malaria	0.0001	0.00197	CbGpPWpGaD
Tacrolimus—Abdominal pain—Quinidine barbiturate—malaria	9.97e-05	0.000393	CcSEcCtD
Tacrolimus—Body temperature increased—Quinidine barbiturate—malaria	9.97e-05	0.000393	CcSEcCtD
Tacrolimus—Body temperature increased—Pentoxifylline—malaria	9.95e-05	0.000393	CcSEcCtD
Tacrolimus—Abdominal pain—Pentoxifylline—malaria	9.95e-05	0.000393	CcSEcCtD
Tacrolimus—Pruritus—Quinidine—malaria	9.89e-05	0.00039	CcSEcCtD
Tacrolimus—Pruritus—Quinine—malaria	9.89e-05	0.00039	CcSEcCtD
Tacrolimus—Diarrhoea—Clindamycin—malaria	9.75e-05	0.000385	CcSEcCtD
Tacrolimus—FKBP1A—Spinal Cord Injury—IL6—malaria	9.67e-05	0.00191	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CRP—malaria	9.59e-05	0.00189	CbGpPWpGaD
Tacrolimus—Diarrhoea—Quinidine—malaria	9.56e-05	0.000377	CcSEcCtD
Tacrolimus—Diarrhoea—Quinine—malaria	9.56e-05	0.000377	CcSEcCtD
Tacrolimus—Dizziness—Clindamycin—malaria	9.42e-05	0.000372	CcSEcCtD
Tacrolimus—ABCB1—Allograft Rejection—FAS—malaria	9.42e-05	0.00186	CbGpPWpGaD
Tacrolimus—Vomiting—Dapsone—malaria	9.37e-05	0.000369	CcSEcCtD
Tacrolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	9.3e-05	0.00183	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Quinidine barbiturate—malaria	9.29e-05	0.000367	CcSEcCtD
Tacrolimus—Hypersensitivity—Pentoxifylline—malaria	9.28e-05	0.000366	CcSEcCtD
Tacrolimus—ALB—Selenium Micronutrient Network—CRP—malaria	9.25e-05	0.00182	CbGpPWpGaD
Tacrolimus—Dizziness—Quinidine—malaria	9.24e-05	0.000365	CcSEcCtD
Tacrolimus—Dizziness—Quinine—malaria	9.24e-05	0.000365	CcSEcCtD
Tacrolimus—Headache—Dapsone—malaria	9.23e-05	0.000364	CcSEcCtD
Tacrolimus—PPP3CA—Disease—DHFR—malaria	9.21e-05	0.00181	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—TLR4—malaria	9.19e-05	0.00181	CbGpPWpGaD
Tacrolimus—Vomiting—Clindamycin—malaria	9.06e-05	0.000357	CcSEcCtD
Tacrolimus—Asthenia—Quinidine barbiturate—malaria	9.05e-05	0.000357	CcSEcCtD
Tacrolimus—Asthenia—Pentoxifylline—malaria	9.03e-05	0.000356	CcSEcCtD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—IL6—malaria	9.02e-05	0.00178	CbGpPWpGaD
Tacrolimus—Rash—Clindamycin—malaria	8.98e-05	0.000354	CcSEcCtD
Tacrolimus—Dermatitis—Clindamycin—malaria	8.98e-05	0.000354	CcSEcCtD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL1B—malaria	8.93e-05	0.00176	CbGpPWpGaD
Tacrolimus—Headache—Clindamycin—malaria	8.93e-05	0.000352	CcSEcCtD
Tacrolimus—Pruritus—Quinidine barbiturate—malaria	8.93e-05	0.000352	CcSEcCtD
Tacrolimus—Pruritus—Pentoxifylline—malaria	8.91e-05	0.000351	CcSEcCtD
Tacrolimus—Vomiting—Quinidine—malaria	8.89e-05	0.000351	CcSEcCtD
Tacrolimus—Vomiting—Quinine—malaria	8.89e-05	0.000351	CcSEcCtD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	8.85e-05	0.00174	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CISH—malaria	8.82e-05	0.00174	CbGpPWpGaD
Tacrolimus—Rash—Quinine—malaria	8.81e-05	0.000348	CcSEcCtD
Tacrolimus—Rash—Quinidine—malaria	8.81e-05	0.000348	CcSEcCtD
Tacrolimus—Dermatitis—Quinine—malaria	8.81e-05	0.000347	CcSEcCtD
Tacrolimus—Dermatitis—Quinidine—malaria	8.81e-05	0.000347	CcSEcCtD
Tacrolimus—Headache—Quinidine—malaria	8.76e-05	0.000345	CcSEcCtD
Tacrolimus—Headache—Quinine—malaria	8.76e-05	0.000345	CcSEcCtD
Tacrolimus—Nausea—Dapsone—malaria	8.75e-05	0.000345	CcSEcCtD
Tacrolimus—PPP3CA—Signaling Pathways—TLR9—malaria	8.7e-05	0.00171	CbGpPWpGaD
Tacrolimus—Diarrhoea—Quinidine barbiturate—malaria	8.63e-05	0.00034	CcSEcCtD
Tacrolimus—Diarrhoea—Pentoxifylline—malaria	8.62e-05	0.00034	CcSEcCtD
Tacrolimus—ALB—Selenium Micronutrient Network—ICAM1—malaria	8.5e-05	0.00168	CbGpPWpGaD
Tacrolimus—Nausea—Clindamycin—malaria	8.46e-05	0.000334	CcSEcCtD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	8.39e-05	0.00165	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ACKR1—malaria	8.37e-05	0.00165	CbGpPWpGaD
Tacrolimus—Dizziness—Quinidine barbiturate—malaria	8.34e-05	0.000329	CcSEcCtD
Tacrolimus—Dizziness—Pentoxifylline—malaria	8.33e-05	0.000328	CcSEcCtD
Tacrolimus—MTOR—Immune System—FCGR2B—malaria	8.33e-05	0.00164	CbGpPWpGaD
Tacrolimus—Nausea—Quinine—malaria	8.3e-05	0.000328	CcSEcCtD
Tacrolimus—Nausea—Quinidine—malaria	8.3e-05	0.000328	CcSEcCtD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—malaria	8.15e-05	0.00161	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IFNG—malaria	8.14e-05	0.0016	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—FCGR2A—malaria	8.05e-05	0.00159	CbGpPWpGaD
Tacrolimus—Vomiting—Quinidine barbiturate—malaria	8.02e-05	0.000316	CcSEcCtD
Tacrolimus—Vomiting—Pentoxifylline—malaria	8.01e-05	0.000316	CcSEcCtD
Tacrolimus—Rash—Quinidine barbiturate—malaria	7.95e-05	0.000314	CcSEcCtD
Tacrolimus—Dermatitis—Quinidine barbiturate—malaria	7.95e-05	0.000313	CcSEcCtD
Tacrolimus—Rash—Pentoxifylline—malaria	7.94e-05	0.000313	CcSEcCtD
Tacrolimus—Dermatitis—Pentoxifylline—malaria	7.93e-05	0.000313	CcSEcCtD
Tacrolimus—Headache—Quinidine barbiturate—malaria	7.9e-05	0.000312	CcSEcCtD
Tacrolimus—Headache—Pentoxifylline—malaria	7.89e-05	0.000311	CcSEcCtD
Tacrolimus—Nausea—Quinidine barbiturate—malaria	7.49e-05	0.000296	CcSEcCtD
Tacrolimus—Nausea—Pentoxifylline—malaria	7.48e-05	0.000295	CcSEcCtD
Tacrolimus—MTOR—Immune System—TIRAP—malaria	7.42e-05	0.00146	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC4A1—malaria	7.38e-05	0.00145	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—DECR1—malaria	7.3e-05	0.00144	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL1B—malaria	7.26e-05	0.00143	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HBB—malaria	7.25e-05	0.00143	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL2—malaria	7.24e-05	0.00143	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—DHFR—malaria	7.14e-05	0.00141	CbGpPWpGaD
Tacrolimus—MTOR—IRS-mediated signalling—IL6—malaria	7.07e-05	0.00139	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CR1—malaria	6.9e-05	0.00136	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events—IL6—malaria	6.88e-05	0.00136	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—IL6—malaria	6.82e-05	0.00134	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TLR9—malaria	6.74e-05	0.00133	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL18—malaria	6.67e-05	0.00131	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD40LG—malaria	6.64e-05	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—Insulin receptor signalling cascade—IL6—malaria	6.64e-05	0.00131	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—IL6—malaria	6.64e-05	0.00131	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD8A—malaria	6.57e-05	0.00129	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DHODH—malaria	6.53e-05	0.00129	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—TNF—malaria	6.48e-05	0.00128	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CD4—malaria	6.48e-05	0.00128	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	6.47e-05	0.00127	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IFNG—malaria	6.47e-05	0.00127	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PKLR—malaria	6.37e-05	0.00126	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HLA-B—malaria	6.32e-05	0.00125	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD36—malaria	6.2e-05	0.00122	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IFNG—malaria	6.18e-05	0.00122	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—malaria	5.97e-05	0.00118	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—malaria	5.88e-05	0.00116	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR9—malaria	5.87e-05	0.00116	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL1B—malaria	5.77e-05	0.00114	CbGpPWpGaD
Tacrolimus—MTOR—Disease—G6PD—malaria	5.68e-05	0.00112	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—HPGDS—malaria	5.62e-05	0.00111	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CRP—malaria	5.59e-05	0.0011	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SLC4A1—malaria	5.56e-05	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—IL6—malaria	5.55e-05	0.00109	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—IL6—malaria	5.51e-05	0.00109	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL1B—malaria	5.51e-05	0.00109	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL2—malaria	5.49e-05	0.00108	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TLR4—malaria	5.36e-05	0.00106	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TNF—malaria	5.27e-05	0.00104	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL6—malaria	5.23e-05	0.00103	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DECR1—malaria	5.22e-05	0.00103	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—ICAM1—malaria	5.13e-05	0.00101	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—CD36—malaria	4.91e-05	0.000968	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD40LG—malaria	4.78e-05	0.000941	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—HLA-B—malaria	4.73e-05	0.000932	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HBB—malaria	4.72e-05	0.000931	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD8A—malaria	4.72e-05	0.000931	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DHODH—malaria	4.72e-05	0.000931	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—IL6—malaria	4.72e-05	0.000929	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ACKR1—malaria	4.71e-05	0.000927	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS2—malaria	4.7e-05	0.000927	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—FCGR2A—malaria	4.69e-05	0.000924	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	4.65e-05	0.000916	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD36—malaria	4.64e-05	0.000914	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-B—malaria	4.54e-05	0.000895	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—malaria	4.51e-05	0.000889	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD36—malaria	4.45e-05	0.000878	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—malaria	4.44e-05	0.000875	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL6—malaria	4.25e-05	0.000838	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—malaria	4.24e-05	0.000836	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—malaria	4.22e-05	0.000832	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PKLR—malaria	4.21e-05	0.00083	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—malaria	4.2e-05	0.000828	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—malaria	4.19e-05	0.000825	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CRP—malaria	4.18e-05	0.000824	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—malaria	4.18e-05	0.000824	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DHODH—malaria	4.07e-05	0.000801	CbGpPWpGaD
Tacrolimus—MTOR—Disease—DHFR—malaria	4.02e-05	0.000791	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC4A1—malaria	4.02e-05	0.000791	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—TLR4—malaria	4.01e-05	0.00079	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—HPGDS—malaria	4e-05	0.000788	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—malaria	4e-05	0.000788	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—malaria	3.93e-05	0.000775	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—malaria	3.93e-05	0.000775	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—malaria	3.93e-05	0.000775	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IFNG—malaria	3.91e-05	0.00077	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—malaria	3.9e-05	0.000768	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—malaria	3.86e-05	0.000761	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—malaria	3.85e-05	0.000758	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL2—malaria	3.8e-05	0.000749	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TLR9—malaria	3.79e-05	0.000747	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DECR1—malaria	3.78e-05	0.000744	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD4—malaria	3.77e-05	0.000743	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—G6PD—malaria	3.75e-05	0.000739	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—ICAM1—malaria	3.69e-05	0.000727	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.67e-05	0.000724	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS2—malaria	3.65e-05	0.000719	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DHODH—malaria	3.56e-05	0.000702	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—malaria	3.5e-05	0.00069	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—malaria	3.48e-05	0.000687	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CD4—malaria	3.48e-05	0.000686	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—malaria	3.48e-05	0.000686	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL2—malaria	3.47e-05	0.000684	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—KDR—malaria	3.46e-05	0.000682	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC4A1—malaria	3.46e-05	0.000681	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HBB—malaria	3.41e-05	0.000673	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—malaria	3.38e-05	0.000666	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DECR1—malaria	3.25e-05	0.000641	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PKLR—malaria	3.04e-05	0.0006	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC4A1—malaria	3.03e-05	0.000597	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HBB—malaria	2.94e-05	0.000579	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL18—malaria	2.91e-05	0.000573	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40LG—malaria	2.9e-05	0.000571	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD8A—malaria	2.86e-05	0.000564	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HPGDS—malaria	2.86e-05	0.000564	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—malaria	2.86e-05	0.000563	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DECR1—malaria	2.85e-05	0.000561	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD4—malaria	2.82e-05	0.000557	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-B—malaria	2.76e-05	0.000543	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—malaria	2.75e-05	0.000542	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD4—malaria	2.71e-05	0.000535	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—G6PD—malaria	2.71e-05	0.000535	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD36—malaria	2.7e-05	0.000532	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—malaria	2.7e-05	0.000532	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KDR—malaria	2.68e-05	0.000529	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—malaria	2.68e-05	0.000528	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DHFR—malaria	2.65e-05	0.000523	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SCARB1—malaria	2.63e-05	0.000518	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PKLR—malaria	2.62e-05	0.000516	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HBB—malaria	2.58e-05	0.000508	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—CD36—malaria	2.53e-05	0.000499	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—malaria	2.44e-05	0.00048	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—G6PD—malaria	2.34e-05	0.00046	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR4—malaria	2.34e-05	0.00046	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	2.3e-05	0.000454	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PKLR—malaria	2.3e-05	0.000453	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—malaria	2.24e-05	0.000442	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ICAM1—malaria	2.24e-05	0.000441	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—malaria	2.23e-05	0.00044	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DHODH—malaria	2.2e-05	0.000433	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—malaria	2.08e-05	0.00041	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HPGDS—malaria	2.07e-05	0.000408	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—malaria	2.05e-05	0.000404	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—G6PD—malaria	2.05e-05	0.000403	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—malaria	2.04e-05	0.000402	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	1.97e-05	0.000389	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DHFR—malaria	1.92e-05	0.000378	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SCARB1—malaria	1.9e-05	0.000374	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—malaria	1.88e-05	0.000371	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC4A1—malaria	1.87e-05	0.000368	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HPGDS—malaria	1.78e-05	0.000351	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DECR1—malaria	1.76e-05	0.000346	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—malaria	1.74e-05	0.000343	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—malaria	1.7e-05	0.000336	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DHFR—malaria	1.65e-05	0.000326	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CD36—malaria	1.65e-05	0.000325	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—malaria	1.65e-05	0.000324	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SCARB1—malaria	1.64e-05	0.000322	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HBB—malaria	1.59e-05	0.000313	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HPGDS—malaria	1.56e-05	0.000308	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—malaria	1.53e-05	0.000301	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—malaria	1.52e-05	0.000299	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—malaria	1.52e-05	0.000299	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—malaria	1.51e-05	0.000298	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KDR—malaria	1.51e-05	0.000298	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—malaria	1.46e-05	0.000288	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DHFR—malaria	1.45e-05	0.000285	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SCARB1—malaria	1.43e-05	0.000282	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—malaria	1.42e-05	0.00028	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PKLR—malaria	1.41e-05	0.000279	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—malaria	1.32e-05	0.00026	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—G6PD—malaria	1.26e-05	0.000248	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CD36—malaria	1.19e-05	0.000235	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CD36—malaria	1.03e-05	0.000202	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—malaria	1.02e-05	0.000202	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—malaria	9.79e-06	0.000193	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HPGDS—malaria	9.62e-06	0.00019	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CD36—malaria	8.99e-06	0.000177	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DHFR—malaria	8.92e-06	0.000176	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—malaria	8.9e-06	0.000175	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SCARB1—malaria	8.83e-06	0.000174	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—malaria	8.22e-06	0.000162	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—malaria	5.75e-06	0.000113	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CD36—malaria	5.54e-06	0.000109	CbGpPWpGaD
